Section Arrow
VOR.NASDAQ
- Vor Biopharma Inc
Quotes are at least 15-min delayed:2026/04/09 05:29 EDT
Pre Market
Last
 15.75
+0.005 (+0.03%)
Bid
15.57
Ask
16.9
High 15.76 
Low 15.21 
Volume 364 
Regular Hours (Closed)
Last
 15.745
-1.105 (-6.56%)
Day High 
17.29 
Prev. Close
16.85 
1-M High
19.7 
Volume 
1.82M 
Bid
15.57
Ask
16.9
Day Low
15.6 
Open
16.9 
1-M Low
11.7 
Market Cap 
823.08M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 15.42 
20-SMA 14.55 
50-SMA 14.27 
52-W High 65.8 
52-W Low 2.622 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-70.50/-7.01
Enterprise Value
825.80M
Balance Sheet
Book Value Per Share
-3.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.1831+0.0201+12.33%-- 
Pre Market 0.1649 -0.0182 -9.94%
VRAXVirax Biolabs Group Limited0.15+0.01+7.14%-- 
Pre Market 0.14 -0.01 -6.67%
ELABPmgc Holdings Inc4.5+1.05+30.43%0PE
Pre Market 4.5005 +0.0005 +0.01%
CUECue Biopharma0.2738+0.0856+45.48%-- 
Pre Market 0.2299 -0.0439 -16.03%
GERNGeron Corp1.71-0.03-1.72%-- 
Pre Market 1.7 -0.01 -0.58%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.